Author

Millicent Dockerill

University of GenevaORCID 0000-0003-4657-1637Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Nicolas WinssingeriD· 2 shared Christel VoizeiD· 1 shared Daniel FordiD· 1 shared Darel Martinez BedoyaiD· 1 shared Denis MiglioriniiD· 1 shared Eliana MarinariiD· 1 shared Imala D. AlwisiD· 1 shared Joanna S. T. Liu· 1 shared

Activity by Year

2024-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Nicolas WinssingerORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyCancer Immunology ResearchPeer-reviewedSep 13, 2024

PTPRZ1-targeting RNA CAR-T cells exert antigen-specific and bystander antitumor activity in glioblastoma

Darel Martinez Bedoya, Eliana Marinari, Suzel Davanture…·Denis Migliorini

This study develops and validates anti-PTPRZ1 RNA CAR-T cells for glioblastoma treatment, showing antigen-specific and bystander antitumor activity in preclinical models.

12 citations

𝕏 PostBluesky

BiochemistryNature BiotechnologyPeer-reviewedApr 30, 2024

Development of supramolecular anticoagulants with on-demand reversibility

Millicent Dockerill, Daniel Ford, Simona Angerani…·Nicolas Winssinger

This paper develops supramolecular anticoagulants that can be reversed on demand using a PNA antidote, demonstrating potent in vitro and in vivo anticoagulant activity.

35 citationstop 1%

experimental assaydrug response / drug discovery

𝕏 PostBluesky